Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3631
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04662632 | Abbreviated Protocol for Two-Stage Exchange | ||
| NCT05651932 | A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma | ||
| NCT02094716 | A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies | ||
| NCT06503978 | Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders | ||
| NCT05470608 | Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain | ||
| NCT05607004 | (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer | ||
| NCT00226421 | Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain | ||
| NCT05668585 | A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors | ||
| NCT05386108 | Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer | ||
| NCT04856189 | Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma | ||
| NCT06721689 | PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors | ||
| NCT00635089 | Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis | ||
| NCT03935555 | Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib | ||
| NCT05573685 | Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training | ||
| NCT02635776 | Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) | ||
| NCT06582017 | Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma | ||
| NCT03001076 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) | ||
| NCT04619108 | Thrombosomes for Expanded Access Use | ||
| NCT02815280 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | ||
| NCT01461460 | A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects | ||
| NCT01706523 | Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders | ||
| NCT04608396 | Mechanistic Evaluation of Response in TRD (MERIT) | ||
| NCT03070782 | Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease | ||
| NCT05828303 | A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors | ||
| NCT06967259 | ENA-001 for Opioid Induced Respiratory Depression | ||
| NCT07246980 | Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study | ||
| NCT03495479 | Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance | ||
| NCT06068946 | VK2735 for Weight Management Phase 2 | ||
| NCT07222605 | Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device | ||
| NCT02279823 | A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia | ||
| NCT00389480 | Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies | ||
| NCT02735603 | Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants | ||
| NCT04624659 | A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) | ||
| NCT00479180 | Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use | ||
| NCT02734862 | CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension | ||
| NCT05241470 | Study of ST-100 as Treatment for Dry Eye Disease | ||
| NCT03979066 | Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma | ||
| NCT02259179 | Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers | ||
| NCT03311373 | A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 | ||
| NCT07732400 | A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) | ||
| NCT02876900 | Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. | ||
| NCT02433834 | Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma | ||
| NCT01243411 | A Study of AA4500 in Men With Peyronie's Disease | ||
| NCT04332432 | GT-032 Belapectin Hepatic Impairment | ||
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | ||
| NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
| NCT06244992 | PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01978964 | Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors | ||
| NCT03050736 | Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression | ||
| NCT04854434 | A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations |
